Theracle Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Theracle General Information

Description

Developer of medtech platform intended to advance treatment for neurological conditions. The company's platform combines clinical validation, adaptive therapeutic design, and precision monitoring, enabling healthcare providers and research institutions to access neurotechnology that supports better patient outcomes and contributes to improved standards in neurological care.

Contact Information

Website
www.theracle.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 518 Sycamore Drive
  • Milpitas, CA 95035
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
HealthTech
Corporate Office
  • 518 Sycamore Drive
  • Milpitas, CA 95035
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Theracle Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 06-Oct-2025 Completed Startup
1. Early Stage VC 03-May-2013 Completed Startup
To view Theracle’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Theracle Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Theracle Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026187788-A1 Systems and methods for targeted delivery of a fluid in a recipient Pending 03-Mar-2025
US-11730923-B2 Implantable drug delivery systems, assemblies, and methods Active 08-Jul-2021
US-20230011575-A1 Implantable drug delivery systems, assemblies, and methods Active 08-Jul-2021
US-20230355925-A1 Implantable drug delivery systems, assemblies, and methods Pending 08-Jul-2021
US-20230071660-A1 Delivery of medication to a treatment site within a body Inactive 18-Feb-2020 A61M25/007
To view Theracle’s complete patent history, request access »

Theracle Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Neuroceuticals Venture Capital Minority
InCube Ventures Corporate Venture Capital Minority
To view Theracle’s complete investors history, request access »

Ready to get started?

Request a free trial

Theracle FAQs

  • When was Theracle founded?

    Theracle was founded in 2013.

  • Where is Theracle headquartered?

    Theracle is headquartered in Milpitas, CA.

  • What industry is Theracle in?

    Theracle’s primary industry is Drug Discovery.

  • Is Theracle a private or public company?

    Theracle is a Private company.

  • What is Theracle’s current revenue?

    The current revenue for Theracle is .

  • Who are Theracle’s investors?

    Neuroceuticals and InCube Ventures have invested in Theracle.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process